Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Abie Horowitz

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Schizophrenia Bulletin|June 14, 2026
Comparing Apples to Oranges Obscures Tortoises Beating Hares: The Relationship Between Rate of Antipsychotic Tapering and RelapseMark Abie Horowitz
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 24, 2021
How to reduce and stop psychiatric medicationMark Abie Horowitz, David Taylor
Psychological Medicine|December 2, 2020
Antipsychotics and mortality - more clarity neededDavid Taylor, Mark Abie Horowitz
The Lancet. Psychiatry|July 21, 2023
Addiction and physical dependence are not the same thingMark Abie Horowitz, David Taylor
The Lancet. Psychiatry|June 25, 2019
Tapering of SSRI treatment to mitigate withdrawal symptoms - Authors' replyMark Abie Horowitz, David Taylor
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|December 23, 2024
Deprescribing antidepressants: An integral and neglected component of high-quality prescribing practiceMark Abie Horowitz, David Taylor
The Lancet. Psychiatry|March 10, 2019
Tapering of SSRI treatment to mitigate withdrawal symptomsMark Abie Horowitz, David Taylor
Schizophrenia (Heidelberg, Germany)|December 17, 2025
Helping people to discontinue antipsychotics: if, when and howJoanna Moncrieff, Mark Abie Horowitz
JAMA Psychiatry|January 28, 2026
Interpretation of the HAMLETT StudyMark Abie Horowitz, James O'Neill, David Taylor
Lancet (London, England)|September 26, 2022
Maintenance antipsychotic trials and the effect of withdrawalKlaus Munkholm, Mark Abie Horowitz, Joanna Moncrieff
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Schizophrenia Bulletin|June 14, 2026
Comparing Apples to Oranges Obscures Tortoises Beating Hares: The Relationship Between Rate of Antipsychotic Tapering and RelapseMark Abie Horowitz
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 24, 2021
How to reduce and stop psychiatric medicationMark Abie Horowitz, David Taylor
Psychological Medicine|December 2, 2020
Antipsychotics and mortality - more clarity neededDavid Taylor, Mark Abie Horowitz
The Lancet. Psychiatry|July 21, 2023
Addiction and physical dependence are not the same thingMark Abie Horowitz, David Taylor
The Lancet. Psychiatry|June 25, 2019
Tapering of SSRI treatment to mitigate withdrawal symptoms - Authors' replyMark Abie Horowitz, David Taylor
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|December 23, 2024
Deprescribing antidepressants: An integral and neglected component of high-quality prescribing practiceMark Abie Horowitz, David Taylor
The Lancet. Psychiatry|March 10, 2019
Tapering of SSRI treatment to mitigate withdrawal symptomsMark Abie Horowitz, David Taylor
Schizophrenia (Heidelberg, Germany)|December 17, 2025
Helping people to discontinue antipsychotics: if, when and howJoanna Moncrieff, Mark Abie Horowitz
JAMA Psychiatry|January 28, 2026
Interpretation of the HAMLETT StudyMark Abie Horowitz, James O'Neill, David Taylor
Lancet (London, England)|September 26, 2022
Maintenance antipsychotic trials and the effect of withdrawalKlaus Munkholm, Mark Abie Horowitz, Joanna Moncrieff
Pageof 3